In response to a request for comment issued by the Centers for Medicare & Medicaid Services on its proposed Quality Strategy, the American Hospital Association is calling for more significant alignment of its quality measurement activities in order to reduce the burden on hospitals and providers.
“CMS then could use these goals and objectives to align,” she continues, “and streamline its quality measurement and reporting efforts, measures embedded in payment programs and other regulatory activities, such as conditions of participation and conditions of coverage, to stimulate the accomplishment of the objectives.
In response to a request for comment issued by the Centers for Medicare & Medicaid Services on its proposed Quality Strategy, the American Hospital Association is calling for more significant alignment of its quality measurement activities in order to reduce the burden on hospitals and providers. “We believe that HHS, as a whole, would foster improvement most effectively by establishing clear and meaningful national goals with specific and measurable objectives that could be used throughout the department,” writes Linda Fishman, AHA Senior Vice President of Public Policy and Analysis and Development.AHA has identified three areas where greater alignment would improve the Quality Strategy, which CMS released last year. The first centers of quality measures used for public reporting and payment systems.
Read the full story here: http://bit.ly/1ghj2dC
Source: EHR Intelligence
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Comparing Breast Cancer Treatment Outcomes Between Fee-for-Service and Medicare Advantage
April 4th 2025This study examined postdiagnosis breast cancer treatment outcomes for Medicare Advantage vs fee-for-service (FFS) Medicare in Ohio and found no significant differences overall but disparities for Black patients with FFS Medicare.
Read More